The same evidence discipline, three very different decisions.

A molecule advancing to the clinic, a method replacing an animal test, an algorithm touching a patient — each demands its own boundary, and the same chain of proof.

Biopharma & TechBio

For CSOs, heads of computational R&D, and regulatory science leaders whose AI-derived candidates are advancing toward regulated development.

Explore Biopharma & TechBio

Federal & NAMs

For federal programs, consortia, and translational science teams establishing readiness standards for New Approach Methodologies.

Explore Federal & NAMs

Health Systems

For CMIOs, Chief AI Officers, and AI steering committees accountable for every algorithm touching patient care.

Explore Health Systems

We also work with

CROs & Reference Laboratories

Independent assurance & method validation

For contract research organizations and commercial labs offering high-complexity assay, bioinformatic, and digital pathology services.

Life Science Technology Builders

Evidence programs that drive enterprise adoption

For innovative AI and scientific software companies that need to prove their methods to skeptical biopharma buyers and clinical committees.

Every sector starts the same way.

One system, one decision, one evidence question — scoped in twenty minutes. The sector shapes the frameworks; the discipline stays the same.

or write to [email protected]

Prefer to see the work first? Walk through an eight-week pilot, step by step